QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR
申请人:Abbvie Deutschland GmbH & Co. KG
公开号:US20170260158A1
公开(公告)日:2017-09-14
The present invention relates to quinoline compounds of formula I
wherein the variables are defined as in the claims and the description. The invention further relates to a pharmaceutical composition containing such compounds, to their use as modulators of the 5-HT
6
receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of the 5-HT
6
receptor, and to methods for preventing or treating conditions and disorders which respond to the modulation of the 5-HT
6
receptor.
PREPARATION OF POLYISOCYANATES HAVING ISOCYANURATE GROUPS AND THEIR USE
申请人:BASF SE
公开号:US20130303758A1
公开(公告)日:2013-11-14
The present invention relates to a novel process for preparing polyisocyanates having isocyanurate groups by a partial trimerization of (cyclo)aliphatic diisocyanates in the presence of at least one trimerization catalyst from the group of ammonium salts of lactames and to the use of the thus obtainable polyisocyanates having isocyanurate groups as a polyisocyanate component in polyurethane coatings.